Dr. Reddy’s Settles Revlimid Patent Litigation
On September 17, Bristol Myers Squibb (Celgene) announced the settlement of U.S. patent litigation for revlimid (lenalidomide) with Dr. Reddy’s (Dr. Reddy’s Laboratories Ltd.). Originally,…
On September 17, Bristol Myers Squibb (Celgene) announced the settlement of U.S. patent litigation for revlimid (lenalidomide) with Dr. Reddy’s (Dr. Reddy’s Laboratories Ltd.). Originally,…
According to information from September 16, 2020, that CNBC (Consumer News and Business Channel) announced, that The U.S. government plans to transport a COVID-19 vaccine…